Based on data from the past 90 days ending January 09, 2026, Neumora Therapeutics's three largest insider shareholders are TenPercentOwner Inc Amgen (35.37Mn shares), Director Paul L Berns (7.54Mn shares), Director Kristina Burow (6.09Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Inc Amgen | 35,368,653 | 19 Sep, 2023 | |
| Paul L Berns | Nan | 7,538,101 | 20 Feb, 2025 |
| Kristina Burow | 6,094,624 | 14 Jun, 2024 | |
| Venture Partners X, Llc Arch | 6,046,907 | 29 Oct, 2025 | |
| Venture Partners Xii, Llc Arch | 6,046,907 | 29 Oct, 2025 | |
| Henry O Gosebruch | President & Ceo | 477,345 | 16 Feb, 2024 |
| Carol Y. Suh | Chief Operating Officer | 374,674 | 16 Feb, 2024 |
| Robert A. Lenz | Head Of R&D | 309,092 | 20 Feb, 2025 |
| Joshua Pinto | President | 215,917 | 23 May, 2025 |
| Daljit Singh Aurora | Chief Strategy Officer | 88,935 | 20 Feb, 2025 |
| Llc Fmr | 63,724 | 21 Sep, 2023 | |
| Michael Lee Milligan | Nan | 22,470 | 20 Feb, 2025 |
| Maykin Ho | 20,100 | 14 Jun, 2024 | |
| Alaa Halawa | 20,100 | 14 Jun, 2024 | |
| David Piacquad | 20,100 | 14 Jun, 2024 | |
| Matthew K Fust | 20,100 | 18 Oct, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Nov, 2025 | Daljit Singh Aurora | Common Stock | D | 114,703 | $2.68 | 0 | I | S |
| 27 Oct, 2025 | Kristina Burow | Common Stock | A | 1,915,700 | $2.61 | 6,046,907 | I | P |
| 27 Oct, 2025 | Venture Partners X, Llc Arch | Common Stock | A | 1,915,700 | $2.61 | 6,046,907 | I | P |
| 27 Oct, 2025 | Venture Partners Xii, Llc Arch | Common Stock | A | 1,915,700 | $2.61 | 6,046,907 | I | P |
| 21 May, 2025 | Joshua Pinto | Common Stock | D | 13,202 | $0.00 | 63,750 | D | G |
| 21 May, 2025 | Joshua Pinto | Common Stock | A | 13,202 | $0.00 | 152,167 | I | G |
| 21 May, 2025 | Joshua Pinto | - | - | 152,167 | I | |||
| 21 May, 2025 | Joshua Pinto | - | - | 63,750 | D | |||
| 18 Feb, 2025 | Paul L Berns | Common Stock | D | 13,871 | $1.69 | 7,405,004 | D | S |
| 18 Feb, 2025 | Paul L Berns | - | - | 7,405,004 | D | |||
| 18 Feb, 2025 | Daljit Singh Aurora | Common Stock | D | 8,565 | $1.68 | 88,935 | D | S |
| 18 Feb, 2025 | Joshua Pinto | Common Stock | D | 8,048 | $1.67 | 76,952 | D | S |
| 18 Feb, 2025 | Robert A. Lenz | Common Stock | D | 5,614 | $1.67 | 309,092 | D | S |
| 18 Feb, 2025 | Michael Lee Milligan | Common Stock | D | 1,978 | $1.69 | 22,470 | D | S |
| 27 Dec, 2024 | Paul L Berns | Common Stock | D | 133,097 | $0.00 | 7,685,069 | D | G |
| 27 Dec, 2024 | Paul L Berns | - | - | 133,097 | I | |||
| 27 Dec, 2024 | Paul L Berns | Common Stock | D | 133,097 | $0.00 | 133,097 | I | G |
| 27 Dec, 2024 | Paul L Berns | Common Stock | D | 133,097 | $0.00 | 7,551,972 | D | G |
| 18 Oct, 2024 | Matthew K Fust | - | - | 34,149 | D | |||
| 18 Oct, 2024 | Matthew K Fust | Common Stock | D | 14,049 | $17.03 | 20,100 | D | S |